Skip to main content
Quest Diagnostics

Comparison of SARS-CoV-2 RT-PCR Ct Values Across Multiple Assays With Different Targets

Comparison of SARS-CoV-2 RT-PCR Ct Values Across Multiple Assays With Different Targets

Authors: Pratt GW, Rao LV

Citation: J Appl Lab Med. 2023 Aug 23:jfad057. doi: 10.1093/jalm/jfad057. Online ahead of print.

Specialties: Infectious Disease, COVID-19

Related content

Conference Presentation
Correlates of immunity in SARS-CoV-2 post-vaccine infectious in the Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) Study
Publication
Risk of and duration of protection from SARS CoV 2 reinfection assessed with real world data
Publication
SARS-CoV-2 Spike-Protein Targeted Serology Test Results and Their Association With Subsequent COVID-19-Related Outcomes
Rapid and Accurate Identification of SARS-CoV-2 Variants Using Real Time PCR Assays
Publication
Assessing vulnerability to COVID 19 in high risk populations: the role of SARS CoV 2 spike targeted serology

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.